Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Trileptal granted FDA approval for treatment of epilepsy

Jan. 18, 2000

Agonists and antagonists of orphanin FQ receptor prepared by Roche

Jan. 18, 2000

Clomethiazole: use in spinal cord injury

Jan. 18, 2000

Apollo's neuroprotective vitamin D compounds covered by U.S. patent

Jan. 17, 2000

JAK3 identified as a new target for the treatment of ALS

Jan. 17, 2000

New antioxidants from ADIR particularly useful for treating oxidative stress in the CNS

Jan. 17, 2000

Selective GABA-A alpha5 receptor inverse agonists useful for cognitive impairment

Jan. 14, 2000

Cephalon compounds enhance spinal cord ChAT activity, inhibit kinase activity

Jan. 14, 2000

INDs filed by Anesta for two OTS products

Jan. 14, 2000

Orally active neurotrophic agent SR-57746A may act by inhibiting tyrosine kinase

Jan. 13, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...